STERIS plc has grown revenue 9.4% a year over three years and 14% a year over five, with earnings per share compounding at 95%. Revenue growth, 3-year annual rate: +9.4% (Medical Devices median +9.2%). Revenue growth, 5-year rate: +14%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +95%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 10, FY2017 to FY2026, as filed.

STESTERIS plc

HealthcareUSD

$236.86

$199.4052 weeks$267.17

Is it growing?

Is STE growing?

STERIS plc has grown revenue 9.4% a year over three years and 14% a year over five, with earnings per share compounding at 95%.

+9.4%

Revenue growth, 3-year annual rate · Medical Devices median +9.2% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +14%
Revenue growth, 5-year rate · +9.4% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +95%
Earnings per share, 3-year rate · revenue +9.4% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 10
Years of annual history on file · FY2017 to FY2026, as filed